Pelvipharm at the "House of Lords"
Pelvipharm has participated to the conference on "How to solve the problem of access to human tissues for medical research" on Oct 20, 2009 at the “House of Lords” in London.
The conference brought together key opinion leaders in order to discuss measures to increase access to human tissues for research.
It also addressed practical & ethical considerations in seeking to increase the use of this vital resource.
Presentations from the 2009 Human Tissues conference are available online at www.safermedicines.org/humantissues
For more information, please contact us.
Presentation at the SIU 2009
Pelvipharm at the SIU (Société Internationale d'Urologie) in Shanghai, China, 1 – 5 November 2009.
Pelvipharm presented 1 abstract:
- Moderated poster :
“Cetrorelix Inhibits Contraction of Prostate Strips from Benign Prostatic Hyperplasia (BPH) Patients Induced by the beta1 Adrenoceptor Agonist Phenylephrine"
Presentations at the ICS 2009
Pelvipharm presented 3 abstracts :
- 1 Moderated poster :
“Rho-kinase inhibition impacts neurogenic detrusor overactivity in chronic spinalized rats”
- 2 Non-discussed posters :
“Oxybutynin modifies bladder hyperactivity in conscious spinal cord injured rats via a non dependent C-fiber afferent pathway”
“Potentiation of oxybutynin-induced human detrusor relaxation by a phosphodiesterase 5 inhibitor, udenafil”.
Presentation at CRO-Biotech BIO-Connexion
18 June, 2009
Pelvipharm at the CRO-Biotech BIO-Connexion in Romainville, France
Recently accepted paper in Eur Urol
Combination of Alfuzosin and Tadalafil Exerts an Additive Relaxant Effect on Human Detrusor and Prostatic Tissues In Vitro
Oger S, Behr-Roussel D, Gorny D, Lebret T, Denoux Y, Alexandre L, Giuliano F.
Eur Urol. 2009 May 3. Vol 57, Issue 4, p: 699-707
Presentations at the AUA 2009
- 1 Podium presentation :
“Ozarelix, an LHRH Antagonist, exerts a direct relaxing effect on Human Prostate in vitro”